The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as insulin resistance.
申请公布号
EP2214693(A4)
申请公布日期
2012.04.11
申请号
EP20080846334
申请日期
2008.11.05
申请人
IPSEN PHARMA S.A.S.;BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURE AND MECHANICAL COLLEGE
发明人
HALEM, HEATHER, A.;CULLER, MICHAEL, DEWITT;BUTLER, ANDREW, A.